Log In
Print
BCIQ
Print
Print this Print this
 

Suberohydroxamic acid phenyl ester (SHAPE) (formerly SHP-141)

  Manage Alerts
Collapse Summary General Information
Company TetraLogic Pharmaceuticals Corp.
DescriptionTopical gel formulation of a tissue-targeted histone deacetylase (HDAC) inhibitor
Molecular Target Histone deacetylase (HDAC)
Mechanism of ActionHistone deacetylase (HDAC) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationCutaneous T cell lymphoma (CTCL)
Indication DetailsTreat cutaneous T cell lymphoma (CTCL)
Regulatory Designation

U.S. - Orphan Drug (Treat cutaneous T cell lymphoma (CTCL))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today